Researchers have generated induced pluripotent stem cells from bats, gaining insights into the relationship between bats and viruses. The study may also shed light on bats' remarkable defenses against aging and cancer.
A US study found that COVID-19 vaccination is associated with a lower risk of cardiovascular events, particularly among those with comorbidities. Even partial vaccination was linked to a reduced risk of adverse cardiovascular events. The research suggests that vaccination may have beneficial effects on post-COVID-19 complications.
Researchers from Mount Sinai Health System presented studies on the association between obesity and adverse outcomes in forceps-assisted vaginal deliveries, as well as the utility of cervical length surveillance after cerclage placement for predicting preterm birth. Additionally, a new tool for managing postpartum hemorrhage was showca...
Research found that cocaine use disorder causes significant gene expression changes in brain regions associated with reward and habit formation, contributing to persistent behavioral abnormalities. The study also identified overlapping molecular changes between cocaine and opioid use disorders, offering potential for targeted treatments.
A Phase 2 clinical trial found that patients with notalgia paresthetica experienced a significant reduction in itch intensity after taking oral difelikefalin. The medication, currently approved for chronic kidney disease, has the potential to become the first FDA-approved treatment specifically for this condition.
Researchers will use systems biology approach to identify biomarkers and mechanisms underlying food allergies and atopic dermatitis. The study aims to improve prevention, diagnosis, and clinical management of these conditions.
The study reveals that repeated mutations in the sarZ gene lead to increased severity of MRSA blood stream infections, and that surface protein ClfB plays a critical role in pathogenesis. The findings provide insights into the factors contributing to MRSA virulence and may help uncover new treatment approaches.
Researchers found that mice exposed to WTCPM dust exhibit impaired spatial recognition and memory, as well as changes in genes related to immune-inflammatory responses. The study suggests a peripheral-brain immune inflammatory 'cross-talking' mechanism that may increase cognitive decline risk.
Mount Sinai researchers discovered that age-related macular degeneration (AMD) may be caused by two distinct types of deposits in the retina: drusen and subretinal drusenoid deposits (SDDs). Early intervention with vitamin supplements can slow down drusen formation, while SDDs pose a greater threat to advanced AMD.
Researchers have identified novel candidate drug targets for advanced non-alcoholic fatty liver disease (NAFLD) using innovative methods. A network of cell-to-cell communication driving scarring was uncovered, and one pair of proteins showed promise as a new treatment.
Researchers at Mount Sinai developed a digital marker for coronary artery disease using machine learning and electronic health records. The model accurately measures CAD on a spectrum, revealing distinct gradations of disease risk and survival, which may otherwise be missed with conventional binary frameworks.
Researchers from The Mount Sinai Hospital found that talquetamab, a bispecific antibody, was successful in killing multiple myeloma cells in over 70% of patients. This therapy directs the immune system to target cancer cells and has shown promise even for those who have resisted all other treatments.
Patients with moderate to severe atopic dermatitis showed significant improvement in signs and symptoms while taking rocatinlimab, a novel monoclonal antibody therapy. The treatment has the potential to change the genetic makeup of the disease, leading to lasting results without continued use.
Researchers identified two molecularly distinct subsets of long COVID symptoms with opposing gene expression patterns during acute COVID-19. These findings suggest multiple independent processes leading to different long COVID symptoms, which are already present during the acute infection.
A Mount Sinai study found that certain inflammatory markers can predict which patients are more likely to respond to COVID-19 immunotherapies. The researchers identified a subtype of COVID-19 patients with hyperinflammation who could benefit from pacritinib, an anti-cancer drug.
Researchers identify INPP5D as a key player in the inflammation process contributing to Alzheimer's disease, which may offer new potential targets for therapies. The study found that mice with inactivated INPP5D gene had more plaques covered by microglia, suggesting unexpected results when modulating inflammation genes.
Chronic social defeat stress impairs brain reward function, leading to severe social avoidance. A subset of susceptible mice exhibit heightened activity of lateral septum neurotensin neurons, which inhibit centers encoding social rewards.
A large-scale international study found that patients diagnosed with lung cancer at an early stage via CT screening have a 20-year survival rate of 80 percent. This is compared to the average five-year survival rate for all lung cancer patients, which is 18.6 percent.
A new study from Mount Sinai Hospital finds a strong association between age-related macular degeneration and severe forms of heart disease, including heart failure, heart attacks, and stroke. The study highlights the importance of increased screening for eye disorders to diagnose undetected heart disease.
A recent study published in Cell Reports Medicine has identified 35 genes highly expressed in patients with long-term Lyme disease. These genes may serve as biomarkers for diagnosing the condition, which is often difficult to detect. The findings also suggest new therapeutic targets and could lead to improved management of the disease.
Researchers found significant immunological differences mediating sex differences in COVID-19 responses. Infected females had higher rates of symptoms but lower viral loads, with stronger immune response gene expression and molecular signatures.
A new study has shown that bivalirudin is a safer and more effective anticoagulant than heparin for treating heart attack patients. The trial found that bivalirudin significantly reduced death, major bleeding, and thrombosis in patients undergoing percutaneous coronary intervention.
Researchers have found therapies that can help patients with relapsed multiple myeloma who tried CAR-T therapy, including bispecific antibodies and other types of CAR-T cell therapy. The study analyzed 79 patients and found that stem cell transplants and other drug combinations showed some efficacy in these patients.
A new metric estimates cumulative exposure to PFAS chemicals, enabling comparisons across studies and applications. The calculator takes into account patterns of exposure to multiple chemicals, providing a robust tool for biomonitoring and disease assessment.
Mount Sinai researchers catalogued thousands of sites in the brain where RNA is modified throughout the human lifespan, increasing with age. This study provides a model depicting how A-to-I editing evolves over a lifetime, shedding light on its role in health and disease.
A recent study found that immigrant pregnant people faced persistent inequities in obtaining timely prenatal care compared to native-born individuals, exacerbating longstanding health disadvantages. The study highlights the need for policymakers to address disparities in Medicaid coverage based on immigration status and education level.
Mount Sinai researchers created a cloud-based digital framework, Employee Health COVID-19 REDCap Registry, to track employee health data and mitigate COVID-19 spread. The platform reduced case follow-up times from days to hours and helped identify occupational and non-occupational risk factors.
Researchers have developed a new therapy that uses CAR T cells to target macrophages in tumors, reducing their growth and increasing anti-tumor immunity. The treatment was shown to be effective in preclinical models of ovarian, lung, and pancreatic cancers.
A new stem cell study provides insight into how neurons from individuals with post-traumatic stress disorder (PTSD) respond to stress hormones. The research found that these cells are hypersensitive to the stress hormone hydrocortisone, which could help explain why some people develop PTSD after trauma exposure.
Researchers discovered two distinct types of regret linked to separate parts of the brain, influencing stress response and mood disorders. Stress-susceptible mice were hypersensitive to one type, while healthy mice were sensitive to another.
Researchers at Mount Sinai's Tisch Cancer Institute have discovered a new gene, PDZK1IP1, essential to colon cancer growth. The study found that surrounding inflammation activates the super enhancer, promoting tumor cell survival and growth.
A study found impairments in the prefrontal cortex-habenula circuit, critical for regulating executive functions and reward, in people with cocaine or heroin addiction. The circuit's microstructural features were analyzed using diffusion MRI tractography, revealing reduced coherence in white matter fibers.
Researchers identified TDRD7 as a key regulator against influenza A virus and found that inhibiting its function increases virus replication. The study's findings could inform the development of novel therapeutic interventions against influenza virus infection in humans.
Researchers at Mount Sinai found that COVID-19 severity is associated with a shift in macrophage populations, leading to inflammation and tissue damage. Restoring reparative lung resident macrophages may be a viable therapeutic strategy for treating SARS-CoV-2 and other inflammatory lung diseases.
The study found that a combination of NOX1, loss of function, and TNF leads to an abnormal increase in microfold cells, driving increased recruitment of immune cells. Reversing the defect with reactive oxygen species restored healthy gut balance. Further studies on reactive oxygen species-stem cell modulation therapy are proposed.
A new study finds that consistently losing an hour and a half of sleep per night can negatively impact immune stem cells, leading to increased inflammation and cardiovascular disease. Even after catching up on sleep, the effects of disrupted sleep remain long-lasting.
The study used a weakly supervised deep learning algorithm to analyze human brain autopsy tissues and predict the presence or absence of cognitive impairment. The model identified a signal associated with decreasing myelin staining, which was linked to cognitive impairment in the white matter.
Researchers discovered a type of triple-negative breast cancer cell that can trigger dormancy, evading therapies and allowing for efficient survival in distant organs. This finding highlights the need for more selective therapeutic strategies targeting both dividing and invasive dormant cells.
Valentin Fuster, MD, PhD, is honored with the TCT Career Achievement Award for his transformative work in interventional cardiology and patient care. He has made significant global contributions to cardiovascular medicine.
Bladder cancer researchers discovered a subset of CD8 T cells that adapts to tumor evasion strategies, offering a strategy to reduce tumor cells' ability to fight them off. The study also identified potential ways to make immunotherapy more effective against this deadly cancer by targeting the HLA-E/NKG2A axis.
Researchers at Mount Sinai have produced a high-resolution crystal structure of the nsp14 enzyme essential to SARS-CoV-2 survival. This discovery could lead to the design of new antivirals to combat current and future coronaviruses.
Scientists have discovered a potential path against inherited neurodegenerative diseases by increasing the activity of TRAP1, which promotes mitochondrial protein-folding and corrects lysosomal dysfunction. This approach may have implications for treating multiple disorders affecting the central nervous system.
A new study suggests that low-dose ketamine is generally safe and effective in treating clinical symptoms of children diagnosed with ADNP syndrome, a rare neurodevelopmental disorder. The treatment resulted in improvements in social behavior, attention deficit, and hyperactivity, as well as reduced aggression.
A study of NASA astronauts found DNA mutations associated with spaceflight, increasing the risk of cardiovascular disease and blood cancer. Regular screening is recommended to monitor astronaut health.
A new risk score can help predict mortality for patients with atrial fibrillation who have undergone successful TAVR and been discharged home. The risk score was developed using data from the ENVISAGE-TAVI AF trial, which found that patients with certain clinical risks were more likely to die within a year of discharge.
The SECURE trial found that the polypill, containing aspirin, ramipril, and atorvastatin, achieves clinically relevant reductions in recurrent cardiovascular events among patients recovering from a heart attack. This simplified approach improves treatment adherence, leading to a 33% reduction in cardiovascular mortality.
A new study of over 150,000 participants has identified more than 70 genes strongly associated with autism and over 250 with strong links to the condition. The analysis provides insights into the molecular roots of brain development and neurodiversity.
A comprehensive analysis of interstitial lung disease diagnosis and treatment in patients who received an antibody drug conjugate known as T-DXd found that close monitoring and proactive management can reduce the risk of ILD. The study results suggest that patient awareness and ongoing education can aid in early detection.
A team of researchers from The Mount Sinai Hospital has made a groundbreaking discovery into the genetic and molecular mechanisms that predispose individuals to Alzheimer's disease. They identified 21 candidate risk genes, including SPI1, which regulates microglia and AD risk.
A team of researchers at Mount Sinai discovered a molecular mechanism involving carbohydrate response-element binding protein (ChREBP) that plays a key role in glucose toxicity and beta-cell death. Increasing expression of an alternate form of ChREBP or activating nuclear factor-erythroid factor 2 can preserve beta-cell mass.